Paediatric Oncology Related Content

The Imaging and Radiation Oncology Core is part of the U.S. National Cancer Institute’s clinical trial program and provides quality assurance for trials with radiation oncology and/or imaging.

Research reveals a global link between COVID-19 and the capacity of paediatric oncology health professionals to provide high quality care.

Dr Martin English, Consultant Paediatric Oncologist and member of the Royal College of Paediatrics and Child Health (RCPCH) explains the challenge of curing cancer in the world’s children

Ivan Stamenkovic, Professor of Experimental Pathology at University of Lausanne explores the paediatric sarcoma metastasis and why this warrants an in-depth look Metastasis is responsible for 90% of cancer–related death. Several solid paediatric malignancies, particularly sarcomas, display high metastatic proclivity, which renders their prognosis poor, as metastases are for the...

Professor Ruth Ladenstein from SIOPE (the European Society for Paediatric Oncology) discusses how ERN PaedCan facilitates effective cross-border healthcare The European Commission launched 24 different networks to bring together experts from across the EU to tackle rare diseases by improving diagnosis, treatment and access to specialist care. These are known...

Ivan Stamenkovic, professor of experimental pathology at the University of Lausanne underlines research taking place around cancer progression Cancer progression, meaning the evolution of localised tumour growth to an invasion of adjacent tissue and dissemination to distant organs is a complex process that is intimately related to interactions between tumour...

A new direction in the monitoring of brain injury in babies, pioneered by a team of physicists, engineers and doctors in University College London (UCL) and University College London Hospitals (UCLH)

Experts from the University of Lausanne explore progress being made in the treatment of paediatric cancer in this fascinating ebook

Epigenetic changes play a critical role in the development of paediatric cancers. Ivan Stamenkovic, Professor of Pathology, explains

SIOPE asks why therapies made available for adults are not extended to children with cancer, and why paediatric oncology drug development is lagging behind Thanks to the increasing introduction of molecular targeting and personalised medicine strategies, innovative medicines and treatments are nowadays available for adults with cancer. Widespread access to...